NDC 80425-0296-01 - Venlafaxine hydrochloride ER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0296
- Requested NDC
- 80425-0296-01
- Package NDCs from labels
- 80425-0296-1, 80425-0296-2, 80425-0296-3, 80425-0296-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Venlafaxine hydrochloride ER - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0296-1 | Venlafaxine hydrochlorideER | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 2 | |
| 80425-0296-2 | Venlafaxine hydrochlorideER | 60 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 60 | 2 | |
| 80425-0296-3 | Venlafaxine hydrochlorideER | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0296 | VENLAFAXINE HYDROCHLORIDE ER (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f89bcae0-e714-599a-e053-6294a90a2c3a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0296-1 | EA - Each | 80425-0296 | 19a8e1c7-fca1-48d6-905f-9e3760d8d660 | 1 | 2023-06-06 |
| 80425-0296-2 | EA - Each | 80425-0296 | 08f25694-74d0-4109-869d-0deeaaad811e | 1 | 2023-06-06 |
| 80425-0296-3 | EA - Each | 80425-0296 | c596b70e-071d-4424-9450-f764a0f86cf8 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e2d5a2d5-5e55-426c-bc8d-d29729eba775 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | ANDA200834 313581 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | AvKARE | 7f224c88-9425-9ef0-01bc-dcf3bdafbd89 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | 313585 313583 313581 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 9fda0f8d-b24e-4581-9dca-7aaaf86e2413 | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | 313585 313583 313581 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE HYDROCHLORIDE | Northwind Health Company, LLC | f2b5c729-17c8-7ecc-e053-2a95a90a2e53 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE HYDROCHLORIDE | Northwind Health Company, LLC | fb076577-b9da-c78b-e053-6394a90a107b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE | Northwind Health Company, LLC | dabfa0f2-0060-f0ee-e053-2a95a90aec9b | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE | Northwind Health Company, LLC | db5f1693-ca64-7a97-e053-2995a90acbff | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Northwind Health Company, LLC | f757cac4-efa7-668c-e053-6294a90a720d | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA200834 313585 7D7RX5A8MO |
| venlafaxine hydrochloride | VENLAFAXINE HYDROCHLORIDE | Chartwell RX, LLC | 85ec2d3f-49e4-4ac5-bd4a-c227589dbf58 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | QPharma, Inc. | 9e745ad7-be4f-4369-be23-587e1154e4ab | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 313585 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | A-S Medication Solutions | 0a1b6bcd-8d46-44ab-bc5d-65515601d2ff | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | 313581 7D7RX5A8MO |
| Venlafaxine | VENLAFAXINE | Ajanta Pharma USA Inc. | 22d4817c-1f19-4490-8a38-d8904f0374f7 | 2025-11-27 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | 349308ef-2caf-4fec-b428-56ae06c6771d | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Major Pharmaceuticals | d962f5af-7642-4c6e-b7be-3e089fe48873 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | ANDA200834 313585 313583 313581 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 22980b32-cbae-4f37-9fc0-b47221b2c32e | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA200834 313585 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | b18d726e-cdb2-4c80-a49d-330cddee17e9 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 313581 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 6c1d0d4f-c8e2-4035-8f4e-7a46bfe3f059 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 313583 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | b055df74-51f9-401f-8cca-24269a0163df | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 313585 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 0c404290-2806-4756-bca3-2d639b400963 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA200834 313583 7D7RX5A8MO |
| venlafaxine hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | de6e30f8-c8ef-4016-b228-0f188645347b | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 313581 7D7RX5A8MO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.